Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Emtricitabine

A cytidine analogue antiretroviral that blocks HIV reverse transcriptase, the enzyme the virus uses to copy its genome: approved in the United States in 2003, it is used in combination with other drugs to treat and prevent HIV infection. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?It was born in a university laboratory: Dennis Liotta, Raymond Schinazi and Woo-Baeg Choi developed it at Emory University in Atlanta. It is also active against the hepatitis B virus.

EmtricitabineGo to the active ingredient →
EmtricitabineActive ingredientEmtricitabineCat. No. P-E038-001CAS 143491-57-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.